Back

Feasibility and outcomes of tailored antiplatelet therapy at a safety-net hospital

21 March 2026 (10:35 - 11:35)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy, fibrinolysis, and clinical registries in acute coronary syndrome Pharmacotherapy ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Sylvie Hall

Bellevue Hospital Center, New York (United States of America)

4 More presentations in this session

Presentation thumbnail
Comparative efficacy and safety of de-escalation, abbreviation, and standard potent P2Y12 inhibitor based DAPT strategies after acute coronary syndrome: a network meta analysis
Mrs Y. Wu (Taipei, TW)
Abstract
Presentation thumbnail
Armenian national registry of myocardial infarction (ARMI): first results from a nationwide prospective stemi registry
Doctor M. Sargsyan (Yerevan, AM)
Abstract
Presentation thumbnail
Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry
Doctor M. Yildirim (Heidelberg, DE)
Abstract
Presentation thumbnail
Impact of P2Y12 inhibitor pretreatment before coronary angiography in high risk NSTE-ACS: A comparative cohort analysis
Doctor L. Garcia Linacero (Madrid, ES)
Abstract

Access the full session

Session thumbnail
Pharmacotherapy, fibrinolysis, and clinical registries in acute coronary syndrome

The Event

Event poster

ESC Acute CardioVascular Care 2026

21 March 2026 10:35 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources